Cervical Cancer Vaccines Market Overview
Cervical cancer vaccines are used for treatment of cervical cancers in women. Human papillomavirus infections are the main cause of cervical cancer. Further, cervical cancer is found in lower part of the uterus and should be treated if found earlier. There are two types of cervical cancer vaccines such as cervarix and gardasil. These vaccines are given to the girls at early ages (under 15 year age) and women up to age up to 26 years can also take these vaccines.
Market Size and Forecast
Global cervical cancer vaccines market is anticipated to expand at a robust compound annual growth rate (CAGR) during the forecast period i.e. 2017-2024. Further, global market of cervical cancer vaccines are anticipated to reach at a valuation of USD 1.8 Billion by the end of forecast period. Factors such as rising awareness towards cervical cancer vaccines and growing prevalence of cervical cancers in women all across the globe are likely to bolster the growth of global cervical cancer vaccines market during the forecast period.
Global cervical cancer vaccines market is segmented into vaccine type, age group and region. Further, age group segment is sub segmented into 9-15 years and 15-26 years. Likely, 9-15 years is the dominating segment in the global cervical cancer market. This growth of 9-15 years is attributed to the huge adoption by this age group to immune from future cervical cancer.
Regionally, global cervical cancer vaccines market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Among these regions, North America is the major market of cervical cancer vaccines. Rising prevalence of cervical cancer vaccines and growing awareness campaign by different NGOs are some dynamic factors which are likely to drive the growth of cervical cancer market in North America region.
Further, Europe region is also anticipated to witness significant growth during the forecast period owing to growing awareness regarding cervical diseases amongst the consumers. Additionally, Asia Pacific region is expected to witness huge demand for cervical cancer vaccines during the forecast period. Rising prevalence of cervical cancer in emerging countries due to lack of awareness and favorable initiatives by government and world health organization (WHO) in emerging countries are some major factors which are likely to foster the growth of Asia Pacific cervical cancer vaccines market in near future.
Market Segmentation
Our in-depth analysis has segmented global cervical cancer vaccine market into the following segments:
By Vaccine Type
- Cervarix
- Gardasil
By Age Group
- 9-15 Years
- 15-26 Years
By Region
Global cervical cancer vaccine market is further classified on the basis of region as follows:
- North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
Growth Drivers & Challenges
Global cervical cancer vaccines market is primarily driven by growing incidents of cervical cancers all across the world. Factors such as rising awareness regarding cervical cancer coupled with favorable government initiatives to provide these vaccines to the consumers are driving the growth of global market of cervical cancer vaccines market.
Further, world health organization’s initiatives and other NGO’s campaigns regarding promotion and distribution of cervical cancer vaccines are anticipated to foster the growth of global market of cervical cancer vaccines.
However, lack of awareness regarding cervical cancer vaccines amongst the consumers is a major challenge to the growth of global cervical cancer vaccines market. Further, misconceptions amongst the consumers regarding use of cervical cancer vaccines such as infertility and other side effects are likely to hamper the growth of global cervical cancer vaccine market in near future.
Top Featured Companies Dominating the Market
- Merck & Co.Inc.
- Company Overview
- Key Product Offerings
- Business Strategy
- SWOT Analysis
- Financials
- GlaxoSmithKline Pharmaceuticals Company
